Related Experiment Video
Updated: Jun 16, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Mania possibly induced by desvenlafaxine.
Rachna Kalia1, Rhanda M Magsalin, Ahsan Y Khan
1Department of Psychiatry, Columbia University College of Physicians and Surgeons, USA.
Journal of Psychiatric Practice
|January 26, 2010
Summary
This case study reports the first instance of desvenlafaxine triggering mania in a major depressive disorder patient. It highlights the importance of considering the bipolar spectrum in antidepressant-induced mania.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Major depressive disorder (MDD) is a common psychiatric condition.
- Antidepressants are a primary treatment for MDD.
- The bipolar spectrum encompasses conditions characterized by mood fluctuations.
Observation:
- A patient with a history of MDD, without prior mania or hypomania, developed an episode of mania.
- The manic episode occurred after the initiation of desvenlafaxine treatment.
- Desvenlafaxine is a newer antidepressant medication.
Findings:
- This is the first documented case of desvenlafaxine-induced mania.
- The findings suggest a potential link between desvenlafaxine and manic episodes.
- The patient had no prior history suggestive of bipolar disorder.
Implications:
- This case underscores the need to consider the bipolar spectrum in patients presenting with new-onset mania during antidepressant therapy.
- Clinicians should be vigilant for manic or hypomanic symptoms in patients treated with desvenlafaxine.
- Further research is warranted to understand the neurobiological mechanisms underlying antidepressant-induced mania.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...